Capsule structure with a sesamin compound
The capsule structure with sesamin and herbal extracts addresses stress and sleep disorders by promoting physiological regulation, achieving effective stress reduction and improved sleep quality.
Patent Information
- Application Number
- DE202024105750
- Authority / Receiving Office
- DE · DE
- Patent Type
- Utility models
- Current Assignee / Owner
- Filing Date
- 2024-10-04
- Publication Date
- 2025-01-09
- Estimated Expiration
- 2034-10-31
AI Technical Summary
Modern society's fast pace and hectic lifestyle lead to psychological stress, irregular work and rest hours, unbalanced diet, and sleep disorders, necessitating the need for effective stress reduction and sleep improvement through healthy foods.
A capsule structure containing a sesamin compound with functional particles comprising sesamin, Lactobacillus brevis ferment, asparagus extract, and chamomile extract, enclosed within a dual-shell capsule body to promote physiological regulation and improve sleep.
The capsule structure effectively calms the mind, reduces stress, and improves sleep disorders by stabilizing physiological functions through the combined action of sesamin, Lactobacillus brevis ferment, and herbal extracts.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
[0001] The present invention relates to a capsule structure, in particular a capsule structure containing a sesamin compound.
[0002] The fast pace of modern society and people's hectic lifestyles have led to psychological stress, irregular work and rest schedules, and unbalanced diets, resulting in physical and mental imbalances, sleep disturbances, tension and anxiety, and other symptoms that impair the normal physiological function of the human body. Therefore, in order to maintain or improve health in a short period of time, modern people generally choose to consume healthy foods to improve and regulate their physiological functions.
[0003] Therefore, the question of how to reduce stress and improve sleep disorders by consuming healthy foods to support the regulation of physiological functions has become an important issue to be resolved in this technical field.
[0004] Based on the disadvantages of the prior art, the present invention aims to provide a capsule structure containing a sesamin compound. The capsule structure containing a sesamin compound according to the present invention can achieve the effect of effectively calming the mind, reducing stress, and improving sleep disorders.
[0005] To achieve this objective, the present invention proposes a capsule structure containing a sesamin compound, comprising a capsule body and a plurality of functional particles. The capsule body has a first capsule shell and a second capsule shell, wherein the first capsule shell and the second capsule shell are placed one upon the other to jointly enclose a closed receiving space. The functional particles are arranged in the receiving space of the capsule body. The composition of the functional particles includes sesamin, Lactobacillus brevis ferment, asparagus extract, and chamomile extract.
[0006] In one embodiment of the present invention, the first capsule shell has a first closed end and a first engagement end opposite the first closed end, and the second capsule shell has a second closed end and a second engagement end opposite the second closed end, wherein the outer diameter of the second engagement end corresponds to the inner diameter of the first engagement end of the first capsule shell, so that the second capsule shell snaps into the first capsule shell.
[0007] In one embodiment of the present invention, the content of sesamin is 5 mg to 15 mg, the content of Lactobacillus brevis ferment is 165 mg to 500 mg, the content of asparagus extract is 65 mg to 200 mg, and the content of chamomile extract is 30 mg to 100 mg.
[0008] In one embodiment of the present invention, the Lactobacillus brevis ferment contains 20 wt% gamma-aminobutyric acid with respect to the Lactobacillus brevis ferment.
[0009] In one embodiment of the present invention, the composition of the plurality of functional particles further comprises L-tryptophan, vitamin B6, vitamin B12, vitamin D, calcium and magnesium.
[0010] In one embodiment of the present invention, the content of L-tryptophan is 15 mg to 49 mg, the content of vitamin B6 is 0.6 mg to 1.8 mg, the content of vitamin B12 is 9 µg to 2.8 µg, the content of vitamin D is 3 µg to 10 µg, the content of calcium is 13 mg to 40 mg and the content of magnesium is 34 mg to 102 mg.
[0011] One of the advantageous effects of the present invention is that the capsule structure containing a sesamin compound according to the present utility model can effectively promote metabolism and regulate physiological functions to effectively stabilize the mind, reduce stress, and improve sleep disorders through the technical solutions of “the first capsule shell and the second capsule shell are stacked on top of each other to collectively form a closed accommodating space” and “a plurality of functional particles are arranged in the accommodating space of the capsule body, wherein the composition of the plurality of functional particles includes sesamin, Lactobacillus brevis ferment, asparagus extract, and chamomile extract.”
[0012] For a better understanding of the features and technical content of the invention, reference is made to the following detailed description and the drawings of the present invention, which, however, are for illustrative purposes only and are not intended to limit the scope of the present invention. Fig. 1 shows a schematic three-dimensional external view of a capsule structure of a second embodiment of the present invention, Fig. 2 shows a schematic three-dimensional exploded view of a capsule body of the second embodiment of the present invention and Fig. 3 shows a schematic three-dimensional perspective view of the capsule structure of the second embodiment of the present invention.
[0013] In the following, the embodiments of a capsule structure with a sesamin compound disclosed within the scope of the present invention are described using specific concrete exemplary embodiments. Those skilled in the art will appreciate that advantages and technical effects of the present invention can be derived from the disclosures in the present description. The invention can be implemented or applied through other concrete exemplary embodiments, and various modifications or changes can be made to the details disclosed in the present description as needed and for specific applications, without departing from the basic ideas of the present invention. Furthermore, it should be noted that the individual components of the present invention are not shown in their actual size, but only schematically.The following embodiments serve to further describe the embodiments of the invention in more detail, but the corresponding disclosures do not represent a limitation of the scope of the invention.
[0014] It should be understood that the terms "first", "second", "third", etc., which may be used to describe various elements or signals, are not intended to be limiting. Rather, such terms are used to distinguish one element from another or one signal from another. Furthermore, as used in this description, the term "or" may include any one or a combination of such items, if any. Further, as used in this description, the term "or" may include any one or a combination of such items, if any. [First embodiment]
[0015] The first embodiment of the present invention provides a composition for improving sleep disorders, comprising, among other ingredients, sesamin, Lactobacillus brevis ferment, asparagus extract, and chamomile extract. In an effective dose of the composition, the sesamin is present in an amount of 5 mg to 15 mg, the Lactobacillus brevis ferment in an amount of 165 mg to 500 mg, the asparagus extract in an amount of 65 mg to 200 mg, and the chamomile extract in an amount of 30 mg to 100 mg.
[0016] In the present embodiment, the sesamin content in an effective dose of the composition is 5 mg to 15 mg. It is worth noting that in the present invention, the sesamin is obtained by extracting sesamin at a concentration of 97% or more. Sesamin is an active ingredient contained in each sesame seed at a content of less than 1% and has the function of regulating physiological functions and stabilizing sleep quality. In some other embodiments, the sesamin content in an effective dose of the composition may also be 5 mg, 6 mg, 7 mg, 8 mg, 9 mg, 10 mg, 11 mg, 12 mg, 13 mg, 14 mg, or 15 mg. However, the invention is not limited to the above examples.
[0017] In the present invention, the content of Lactobacillus brevis ferment in an effective dose of the composition is 165 mg to 500 mg. The Lactobacillus brevis ferment is a fermentation product of Lactobacillus brevis containing 20% by weight of gamma-aminobutyric acid (GABA) with respect to the Lactobacillus brevis ferment. GABA is an important neurotransmitter that may contribute to emotional relaxation, maintaining calmness, stress regulation, and promoting sleep. GABA derived from a Lactobacillus brevis ferment may exhibit better bioavailability and contribute to stress reduction and improving sleep disorders. In some other embodiments, the content of Lactobacillus brevis ferment in an effective dose of the composition may also be 165 mg, 175 mg, 200 mg, 225 mg, 250 mg, 275 mg, 300 mg, 325 mg, 350 mg, 375 mg, 400 mg, 425 mg, 450 mg, 475 mg or 500 mg.However, the invention is not limited to the above examples.
[0018] Asparagus is a vegetable with a high folic acid content and also contains a number of active ingredients such as flavonoids, saponins, and hydroxycinnamic acid esters. Asparagus extract can relieve fatigue, reduce stress, aid sleep, and boost immunity. In the present invention, the content of asparagus extract in an effective dose of the composition is 65 mg to 200 mg. In some other embodiments, the content of asparagus extract in an effective dose of the composition may also be 65 mg, 75 mg, 100 mg, 125 mg, 150 mg, 175 mg, or 200 mg. However, the invention is not limited to the above examples.
[0019] In the present invention, the content of chamomile extract in an effective dose of the composition is 30 mg to 100 mg. In the present embodiment, the chamomile extract is obtained by a 4-fold concentrated extraction. Chamomile extract contains a variety of flavonoid active ingredients such as apigenin, hyperoside, rutin, and chlorogenic acid, which enable chamomile extract to regulate physiological functions, stabilize emotions, and reduce stress. In some other embodiments, the content of chamomile extract in an effective dose of the composition can also be 30 mg, 40 mg, 50 mg, 60 mg, 70 mg, 80 mg, 90 mg, or 100 mg. However, the invention is not limited to the above examples.
[0020] In addition, in the present embodiment, the composition for improving sleep disorders may further contain L-tryptophan, vitamin B6, vitamin B12, vitamin D, calcium, and magnesium. L-tryptophan may contribute to the regulation of physiological functions, while vitamin B6 may support the conversion of L-tryptophan to niacin, thereby achieving the sleep-aid effect. Vitamin D and calcium may contribute to normal neuromuscular physiology and appropriate relaxation of the body. Magnesium aids sleep and calms the mind. In the present embodiment, in an effective dose of the composition, the content of L-tryptophan is 15 mg to 49 mg, the content of vitamin B6 is 0.6 mg to 1.8 mg, the content of vitamin B12 is 9 µg to 2.8 µg, the content of vitamin D is 3 µg to 10 µg, the content of calcium is 13 mg to 40 mg and the content of magnesium is 34 mg to 102 mg.
[0021] However, the invention is not limited to the above examples. [Second embodiment]
[0022] As in Fig. 1 to 3, the second embodiment of the present invention provides a capsule structure C with a sesamin compound comprising a capsule body 10 and a plurality of functional particles 20.
[0023] The capsule body 10 has a first capsule shell 11 and a second capsule shell 12, wherein the first capsule shell 11 and the second capsule shell 12 are placed on top of one another such that they together enclose a closed receiving space 13. The functional particles 20 are arranged in the receiving space 13 of the capsule body 10. However, the invention is not limited to the above-mentioned example.
[0024] Specifically, the first capsule shell 11 has a first closed end 111 and a first contact end 112 opposite the first closed end 111, and the second capsule shell 12 has a second closed end 121 and a second contact end 122 opposite the second closed end 121. The outer diameter of the second contact end 122 corresponds to the inner diameter of the first contact end 112 of the first capsule shell 11, so that the second capsule shell 12 can snap into the first capsule shell 11 to create the closed receiving space 13 for receiving the functional particles 20. The functional particles 20 can be in the form of powder particles, granules, or powders.
[0025] In the present embodiment, the plurality of functional particles 20 is the composition for improving sleep disorders from the first embodiment. In other words, the composition of the plurality of functional particles 20 comprises at least sesamin, Lactobacillus brevis ferment, asparagus extract, and chamomile extract, i.e., the composition of the functional particles 20 is a sesamin compound. In an effective dose of the composition, the sesamin is present in an amount of 5 mg to 15 mg, the Lactobacillus brevis ferment in an amount of 165 mg to 500 mg, the asparagus extract in an amount of 65 mg to 200 mg, and the chamomile extract in an amount of 30 mg to 100 mg. However, the invention is not limited to the above examples.
[0026] It should be noted that the receiving space 13 of the capsule body 10 can provide a good preservation environment for the functional particles 20. When hermetically packaging the plurality of functional particles 20 into the receiving space 13, the receiving space can be filled with dry air to make the functional particles 20 less susceptible to deterioration. However, the above example represents only one possible embodiment and is not intended to limit the scope of the present invention.
[0027] In the present embodiment, the material of the capsule body 10 may comprise at least gelatin, purified water, sodium lauryl sulfate and glycerin. [Third embodiment]
[0028] In the present embodiment, a total of 12 men and women with sleep disorders were administered capsule structure C of the second embodiment of the present invention, 3 capsules per day. Note that in the present embodiment, the composition of the functional particles includes sesamin, Lactobacillus brevis ferment, asparagus extract, and chamomile extract. Each capsule structure C contains sesamin in an amount of about 5 mg, Lactobacillus brevis ferment in an amount of about 165 mg (20 wt% GABA), asparagus extract in an amount of about 65 mg, chamomile extract in an amount of about 30 mg, L-tryptophan in an amount of about 15 mg, vitamin B6 in an amount of about 0.6 mg, vitamin B12 in an amount of about 9 µg, vitamin D in an amount of about 3 µg, calcium in an amount of about 13 mg and magnesium in an amount of about 34 mg.An improvement in sleep disturbances was observed in the 12 men and women starting from the 30th day after daily intake of 3 capsule structures C. [Advantageous effects of the embodiments]
[0029] One of the advantageous effects of the present invention is that the capsule structure containing a sesamin compound according to the invention can effectively promote metabolism and regulate physiological functions to effectively stabilize the mind, reduce stress, and improve sleep disorders through the technical solutions of “the first capsule shell and the second capsule shell are stacked to form a closed accommodation space” and “a plurality of functional particles are arranged in the accommodation space of the capsule body, the composition of the plurality of functional particles comprising sesamin, Lactobacillus brevis ferment, asparagus extract, and chamomile extract.”
[0030] The above disclosure merely represents preferred possible embodiments of the present invention and is not intended to limit the scope of the claims of the present disclosure, so that all equivalent technical changes made by applying the contents of the description and the drawings of the invention are included within the scope of the claims of the present invention. List of reference symbols C Capsule structure 10 capsule bodies 11 First capsule shell 111 First closed end 112 First touchdown 12 Second capsule shell 121 Second closed end 122 Second touchdown 13 Recording room 20 Functional Particles
Claims
[1] Capsule structure (C) with a sesamin compound comprising: - a capsule body (10) having a first capsule shell (11) and a second capsule shell (12), wherein the first capsule shell (11) and the second capsule shell (12) are placed on top of one another in such a way that they jointly enclose a closed receiving space (13); and - a plurality of functional particles (20) arranged in the receiving space (13) of the capsule body (10), wherein the composition of the plurality of functional particles (20) contains sesamin, Lactobacillus brevis ferment, asparagus extract and chamomile extract. [2] The capsule structure (C) containing a sesamin compound according to claim 1, wherein the first capsule shell (11) has a first closed end (111) and a first engaging end (112) opposite the first closed end (111), and the second capsule shell (12) has a second closed end (121) and a second engaging end (122) opposite the second closed end (121), the outer diameter of the second engaging end (122) corresponding to the inner diameter of the first engaging end (112) of the first capsule shell (11), so that the second capsule shell (12) snaps into the first capsule shell (11). [3] A capsule structure (C) containing a sesamin compound according to claim 1 or 2, wherein the content of sesamin is 5 mg to 15 mg, the content of Lactobacillus brevis ferment is 165 mg to 500 mg, the content of asparagus extract is 65 mg to 200 mg, and the content of chamomile extract is 30 mg to 100 mg. [4] A capsule structure (C) comprising a sesamin compound according to any one of claims 1 to 3, wherein the Lactobacillus brevis ferment contains 20% by weight of gamma-aminobutyric acid with respect to the Lactobacillus brevis ferment. [5] A capsule structure (C) comprising a sesamin compound according to any one of claims 1 to 4, wherein the composition of the plurality of functional particles (20) further comprises L-tryptophan, vitamin B6, vitamin B12, vitamin D, calcium and magnesium. [6] A capsule structure (C) containing a sesamin compound according to claim 5, wherein the content of L-tryptophan is 15 mg to 49 mg, the content of vitamin B6 is 0.6 mg to 1.8 mg, the content of vitamin B12 is 9 µg to 2.8 µg, the content of vitamin D is 3 µg to 10 µg, the content of calcium is 13 mg to 40 mg, and the content of magnesium is 34 mg to 102 mg.